Study Weighs Perceived Benefits, Costs of RDM Adoption for Diabetes Management

January 20th 2021, 1:00pm


Results of a vignette-based survey study indicate patients with diabetes require greater health benefits to adopt more intrusive remote digital monitoring (RDM), food monitoring, and real-time feedback by a health care professional.

Trial Finds Bimagrumab Aids Weight Loss in Patients With T2D, Obesity

January 18th 2021, 7:21pm


Results of a phase 2 trial showed that an activin type II receptor blockade, achieved via bimagrumab, led to significant loss of fat mass, gain in lean mass, and metabolic improvements among patients with type 2 diabetes (T2D) and overweight or obesity.

Black Americans With T1D, COVID-19 Have Increased Risk of Hospitalization for DKA

January 13th 2021, 4:08pm


Non-Hispanic Black individuals with type 1 diabetes and coronavirus disease 2019 infections may be more likely to be hospitalized for diabetic ketoacidosis (DKA) compared with non-Hispanic White patients.

ADA Survey Highlights COVID-19’s Impact on Americans With Diabetes

January 11th 2021, 8:28pm


A new American Diabetes Association (ADA) survey highlights how the coronavirus disease 2019 (COVID-19) pandemic took a toll on the population with diabetes, which is one of the most prevalent preexisting conditions in America.

Jardiance 1 Step Closer to FDA Approval for Use in Heart Failure

January 11th 2021, 6:04pm


The FDA today accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for Jardiance (empagliflozin), the sodium glucose co-transporter 2 inhibitor being investigated for use in patients with heart failure.

Michael Snyder Discusses How Precision Health Measurements Can Impact Diabetes Detection and Management

January 7th 2021, 3:00pm


Michael Snyder, PhD, professor and chair of genetics at the Stanford University School of Medicine, discusses the ways in which precision health measurements can aid physicians in detecting and better managing diabetes.

Improved Periconception A1C Linked to Reduction in Adverse Pregnancy Outcomes

January 4th 2021, 5:50pm


A reduction in glycated hemoglobin (A1C) may result in improved perinatal and maternal outcomes among women with prepregnancy diabetes, according to results of a cohort study published in JAMA Network Open.

Machine Learning Predicts Incidence of Gestational Diabetes

December 30th 2020, 3:15pm


Using advanced machine learning models, researchers in China were able to accurately predict incidence of gestational diabetes among pregnant women during their first trimester.

Irregular Menstrual Cycles Associated With Increased Risk of T2D

December 28th 2020, 3:00pm


In a cohort study of nurses, irregular and long menstrual cycles throughout life were associated with a greater risk of type 2 diabetes (T2D).

Top 5 Most-Read Diabetes Articles of 2020

December 23rd 2020, 3:00pm


Advancements in coverage for diabetes technology and improvement in diabetic retinopathy screening rates appear on this year’s list of most-read diabetes articles.